BJP Stock Overview
Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Beit Jala Pharmaceutical Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | د.أ2.76 |
| 52 Week High | د.أ2.85 |
| 52 Week Low | د.أ2.75 |
| Beta | -0.0084 |
| 1 Month Change | -1.43% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | 0.36% |
| 5 Year Change | n/a |
| Change since IPO | 80.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| BJP | PS Pharmaceuticals | PS Market | |
|---|---|---|---|
| 7D | 0% | 2.5% | 1.9% |
| 1Y | n/a | 10.3% | -0.6% |
Return vs Industry: Insufficient data to determine how BJP performed against the PS Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how BJP performed against the PS Market.
Price Volatility
| BJP volatility | |
|---|---|
| BJP Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in PS Market | 5.7% |
| 10% least volatile stocks in PS Market | 2.6% |
Stable Share Price: BJP's share price has been volatile over the past 3 months compared to the PS market.
Volatility Over Time: Insufficient data to determine BJP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1933 | 214 | n/a | www.beitjalapharma.com |
Beit Jala Pharmaceutical Company engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority. It provides its products in various forms, such as tablets, capsules, powders, oral drops, solutions, suspensions, syrups, sprays, creams, gels, lotions, ampoules, and suppositories. The company also offers medicated shampoos; and sterile products, including eye, ear, and nose drops, as well as ear and nose ointments.
Beit Jala Pharmaceutical Company Fundamentals Summary
| BJP fundamental statistics | |
|---|---|
| Market cap | د.أ19.32m |
| Earnings (TTM) | د.أ2.30m |
| Revenue (TTM) | د.أ10.66m |
Is BJP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BJP income statement (TTM) | |
|---|---|
| Revenue | د.أ10.66m |
| Cost of Revenue | د.أ6.80m |
| Gross Profit | د.أ3.86m |
| Other Expenses | د.أ1.56m |
| Earnings | د.أ2.30m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 36.25% |
| Net Profit Margin | 21.57% |
| Debt/Equity Ratio | 3.9% |
How did BJP perform over the long term?
See historical performance and comparisonDividends
Does BJP pay a reliable dividends?
See BJP dividend history and benchmarks| Beit Jala Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | May 04 2025 |
| Dividend Pay Date | Jun 30 2025 |
| Days until Ex dividend | 28 days |
| Days until Dividend pay date | 29 days |
Does BJP pay a reliable dividends?
See BJP dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/01 07:59 |
| End of Day Share Price | 2025/05/12 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beit Jala Pharmaceutical Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.